Skip to main content Skip to section navigation Skip to footer
Investor Relations
Back to BullFrogAI.com
BullFrog AI Holdings, Inc.
  • Overview
  • News & Events
    • Press Releases
    • In The News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Back to BullFrogAI.com

Press Releases

News & Events

News & Events

  • Press Releases
  • In The News
  • IR Calendar
  • Presentations
  • Email Alerts
Mar 21, 2023 8:30 am EDT

BullFrog AI Now Featured on Webull Corporate Communications Service Platform

Feb 23, 2023 8:00 am EST

BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic

Feb 16, 2023 11:30 am EST

Bullfrog AI Announces Closing of $8.4 Million Initial Public Offering

Feb 15, 2023 10:00 am EST

BullFrog AI to Present at Benzinga All Access Event on Friday, February 17

Feb 14, 2023 9:20 am EST

Bullfrog AI Announces Pricing of Initial Public Offering

Mar 23, 2022 8:00 am EDT

BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
©2025 BullFrog AI Holdings, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap